natgillin/translations-raw huggingface dataset:
By lowering the heart rate, Ivabradine Anpharm reduces the stress on the heart, thereby slowing the progression of heart failure and improving symptoms.
Snižavanjem srčane frekvencije, Ivabradine Anpharm ublažava napor za srce te tako usporava progresiju zatajenja srca i ublažava simptome.
Ivabradine Anpharm was compared with placebo (a dummy treatment) and other treatments in five main studies involving over 4,000 adults with long-term stable angina.
Lijek Ivabradine Anpharm uspoređen je s placebom (prividnim liječenjem) i drugim terapijama u pet glavnim ispitivanja koja su uključivala više od 4000 odraslih s dugoročnom stabilnom anginom.
A sixth study compared Ivabradine Anpharm with placebo in 19,102 patients with coronary artery disease and without clinical heart failure.
U šestom je ispitivanju lijek Ivabradine Anpharm uspoređen s placebom u 19 102 bolesnika s bolešću koronarnih arterija i bez kliničkog zatajenja srca.
It is used in those who cannot be treated with beta blockers (another type of medicine to treat angina) or in combination with a beta blocker in patients whose disease is not controlled by beta blockers alone.
Upotrebljava se u bolesnika koji se ne mogu liječiti beta-blokatorima (drugom vrstom lijeka za liječenje angine) ili u kombinaciji s betablokatorima u bolesnika čiju se bolest ne može kontrolirati samo beta-blokatorima.
As for all medicines, data on the use of Ivabradine Anpharm are continuously monitored.
Kao za sve lijekove, podatci o primjeni lijeka Ivabradine Anpharm kontinuirano se prate.
Ivabradine Anpharm is also used in patients with long-term heart failure (when the heart cannot pump enough blood to the rest of the body) who have a normal heart rhythm and whose heart rate is at least 75 beats per minute.
Ivabradine Anpharm se također upotrebljava u bolesnika s dugoročnim zatajenjem srca (kada srce ne opskrbljuje tijelo dovoljnom količinom krvi) i normalnim srčanim ritmom te srčanom frekvencijom od najmanje 75 otkucaja u minuti.
An overview of Ivabradine Anpharm and why it is authorised in the EU
Pregled informacija o lijeku Ivabradine Anpharm i zašto je odobren u EU-u EU-u
For more information about using Ivabradine Anpharm, see the package leaflet or contact your doctor or pharmacist.
Više informacija o primjeni lijeka Ivabradine Anpharm pročitajte u uputi o lijeku, odnosno obratite se liječniku ili ljekarniku.
Ivabradine Anpharm is a heart medicine used to treat the symptoms of long-term stable angina (pains to the chest, jaw and back, brought on by physical effort) in adults with coronary artery disease (disease of the heart caused by the obstruction of the blood vessels that supply blood to the heart muscle).
Ivabradine Anpharm lijek je za srce koji se upotrebljava za liječenje dugotrajne stabilne angine (boli u prsima, vilici ili leđima pri fizičkom naporu) u odraslih s bolešću koronarnih arterija (bolest srca u kojoj su začepljene žile koje srce opskrbljuju krvlju).
What is Ivabradine Anpharm and what is it used for?
Što je Ivabradine Anpharm i za što se koristi?
Ivabradine Anpharm was compared with placebo in one main study involving over 6,500 patients with long-term moderate to severe heart failure.
Ivabradine Anpharm bio je uspoređen s placebom u jednom glavnom ispitivanju s 6500 bolesnika s dugoročnim, umjerenim do ozbiljnim zatajenjem srca.
The active substance in Ivabradine Anpharm, ivabradine, works by blocking the ‘If currents' in the sinus node, the natural ‘pacemaker' that controls the heart's contractions and regulates the heart rate.
Djelatna tvar u lijeku Ivabradine Anpharm, ivabradin, djeluje blokiranjem „If struja” u sinusnom čvoru, prirodnom elektrostimulatoru srca, koji kontrolira srčane kontrakcije i regulira srčanu frekvenciju.
Why is Ivabradine Anpharm authorised in the EU?
Zašto je lijek Ivabradine Anpharm odobren u EU-u?
Other information about Ivabradine Anpharm
Ostale informacije o lijeku Ivabradine Anpharm
Side effects reported with this medicine are carefully evaluated and any necessary action taken to protect patients.
Nuspojave prijavljene za lijek Ivabradine Anpharm pažljivo se procjenjuju i poduzimaju se potrebne mjere za zaštitu bolesnika.
What are the risks associated with Ivabradine Anpharm?
Koji su rizici povezani s lijekom Ivabradine Anpharm?
Ivabradine Anpharm contains the active substance ivabradine.
Ivabradine Anpharm sadrži djelatnu tvar ivabradin.
How is Ivabradine Anpharm used?
Kako se Ivabradine Anpharm koristi?
The Agency decided that Ivabradine Anpharm's benefits are greater than its risks and it can be authorised for use in the EU.
Europska agencija za lijekove zaključila je da koristi lijeka Ivabradine Anpharm nadmašuju s njim povezane rizike te da lijek može biti odobren za primjenu u Europskoj uniji.
What benefits of Ivabradine Anpharm have been shown in studies?
Koje su koristi od lijeka Ivabradine Anpharm utvrđene u ispitivanjima?
For the full list of restrictions with Ivabradine Anpharm, see the package leaflet.
Potpuni popis ograničenja za lijek Ivabradine Anpharm potražite u uputi o lijeku.
For the full list of all side effects reported with Ivabradine Anpharm, see the package leaflet.
Potpuni popis nuspojava zabilježenih pri primjeni lijeka Ivabradine Anpharm potražite u uputi o lijeku.
The European Medicines Agency concluded that Ivabradine Anpharm was shown to be effective in longterm angina with an acceptable safety profile for it to provide an alternative treatment for patients who cannot take beta blockers or whose disease is not controlled with them.
Njegov je sigurnosni profil prihvatljiv kako bi bio zamjensko liječenje za bolesnike koji ne mogu uzimati beta-blokatore ili u kojih bolest nije moguće kontrolirati beta-blokatorima.
ATCvet code: QI01AD07.
ATCvet kod: QI01AD07.
Each dose of reconstituted vaccine contains:
Svaka doza rekonstituirane vakcine sadrži:
Date of last renewal: 21/05/2008.
Datum zadnje obnove: 21/05/2008.
Each container should be used immediately and completely after opening.
Svaki kontejner treba upotrijebiti u cijelosti odmah po otvaranju.
Store in a refrigerator (2 °C - 8 °C).
Čuvati u hladnjaku (2 - 8°C).
EXP Once reconstituted use within 2 hours.
EXP Jednom rekonstituiran upotrijebiti u roku 2 sata.
Date of first authorisation: 09/06/1998.
Datum prvog odobrenja: 09/06/1998.
These measures should help to protect the environment.
Ove mjere pomažu u očuvanju okoliša.
Do not use this veterinary medicinal product after the expiry date stated on the label.
Ne upotrebljavati ovaj veterinarsko medicinski proizvod nakon isteka datuma naznačenog na naljepnici.
b) the disease to which the product is intended to confer immunity is largely absent from the territory in question.
b) bolest, za koju je veterinarski proizvod namijenjen za stjecanje imuniteta, uglavnom nije prisutna na teritoriju.
Overdose (symptoms, emergency procedures, antidotes):
Predoziranje (simptomi, hitne procedure, antidoti):
In laboratory studies and field trials:
U laboratorijskim i terenskim istraživanjima:
Ask your veterinary surgeon how to dispose of medicines no longer required.
Pitajte vašeg veterinara za odlaganje proizvoda koji nije više potreban.
In post marketing experience: In very rare cases mild respiratory signs of disease are reported.
U iskustvima nakon stavljanja na tržište: U vrlo rijetkim slučajevima prijavljeni su blagi respiratorni simptomi bolesti.
Wash and disinfect hands and equipment after vaccinating to avoid spread of the virus.
Oprati i dezinficirati ruke i opremu nakon cijepljenja da bi se izbjeglo širenje virusa.
Care should be taken to avoid the introduction of the variant strain into an area where it is not present.
Treba paziti da se varijantni soj ne prenese u područje gdje nije prisutan.
THE WORDS "FOR ANIMAL TREATMENT ONLY" AND CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE, IF APPLICABLE
13. RIJEČI “SAMO ZA PRIMJENU NA ŽIVOTINJAMA” I UVJETI ILI OGRANIČENJA U POGLEDU OPSKRBE I PRIMJENE, AKO JE PRIMJENJIVO
CONTENTS BY WEIGHT, BY VOLUME OR NUMBER OF DOSES
SADRŽAJ: TEŽINA, VOLUMEN IL BROJ DOZA
The excipients (including adjuvants) listed in section 6.1 of the SPC are either allowed substances for which table 1 of the annex to Commission Regulation (EU) No 37/2010 indicates that no MRLs are required or considered as not falling within the scope of Regulation (EC) No 470/2009 when used as in this veterinary medicinal product.
Pomoćne tvari (uključujući adjuvanse) navedene u dijelu 6.1 SPC su ili dozvoljene tvari za koje je u tablici 1, Dodatka Uredbe Komisije (EU) br. 37/2010 naznačeno da određivanje MRL nije nužno, ili se smatra da se na njih ne primjenjuju odredbe Uredbe (EK) br. 470/2009 kada se primjenjuju u tim veterinarsko-medicinskim proizvodima.
In case of the product presented in cups, do not use the product if the contents are brownish and stick to the container as this indicates that the integrity of the container has been breached.
U slučaju proizvoda u čašicama, ne upotrebljavati ako je sadržaj smećkast i lijepi se po stranicama jer to ukazuje da je cjelovitost kontejnera upitna.
Simultaneous use of both vaccines increases the risk of recombination of viruses and potential emergence of new variants.
Istovremena primjena povećava rizik rekombinacije virusa i potencijalno razvijanje novih varijanti.
These should be clean and free from traces of detergents and disinfectants.
Posude trebaju biti čiste i bez tragova deterdženta i dezinficijensa.
Pancreatic digest of casein Disodium phosphate Water for injections
Pankreasni digest kazeina Dinatrijev fosfat Voda za injekcije
The safety parameters of the mixed vaccines are not different from those described for the vaccines administered separately.
Parametri neškodljivosti kombiniranog cjepiva se ne razlikuju od onih opisanih kod pojedinačnih cjepiva.
In both cases mix the water containing the vaccine well before use.
U oba slučaja dobro promiješati vodu koja sadrži cjepivo prije primjene.
This will vary according to the age of the chickens being vaccinated and the management system, but 250 to 400 ml of water per 1,000 doses is suggested.
Količina vode će se razlikovati ovisno o dobi pilića i sustavu upravljanja, ali preporučuje se 250 do 400 ml vode za 1000 doza.
Vaccination programme The veterinarian should determine the optimum vaccination schedule according to the local situation.
Program cijepljenja: Veterinar određuje optimalni raspored cijepljenja u skladu s lokalnom situacijom.
For heavy breeds, or in hot weather, the quantity of water may be increased up to 40 litres per 1,000 doses.
Za teške pasmine, ili za vrijeme velikih vrućina, količinu vode možemo povećati i do 40 litara na 1000 doza.
Only skimmed milk should be used, since fat in whole milk may block the automatic drinking systems as well as reduce vaccine virus efficacy.
Samo obrano mlijeko treba koristiti, jer mast u punomasnom mlijeko može zamastiti automatski sustav za napajanje i smanjiti djelotvornost virusnog cjepiva.
For prolonged immunity, chickens should be revaccinated every 6 weeks after the initial administration.
Za dugotrajniju imunost cijepljenje treba ponavljati svakih 6 tjedana nakon prvog cijepljenja.
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal product should be disposed of in accordance with local requirements.
Bilo koji neupotrebljeni veterinarsko-medicinski proizvod ili otpadni materijali dobivenih primjenom tih veterinarsko-medicinskih proizvoda moraju se odlagati u skladu s lokalnim propisima.
The active substance being a principle of biological origin intended to produce active immunity is not within the scope of Regulation (EC) No 470/2009.
Na djelatnu tvar koja se sastoje od tvari biološkog podrijetla, namijenjenu za izazivanje stanja imunosti ne primjenjuju se odredbe Uredbe (EK) br. 470/2009.
Feed should be available when vaccinating.
Hrana treba biti dostupna tijekom cijepljenja.
Guideline when the product is used with Nobilis IB Ma5
Smjernice kada se proizvod koristi s Nobilis IB Ma5:
Shelf life of the veterinary medicinal product in aluminium laminate cups as packaged for sale: 24 months.
Rok valjanosti veterinarsko medicinskog proizvoda u laminiranoj aluminijskoj čašici pakiranoj za prodaju: 24 mjeseca.
Chickens should be vaccinated against other prevalent IBV serotypes (e.g. Massachusetts) according to the local IB vaccination programme.
Pilići trebaju biti cijepljeni protiv drugih prevalentnih ZBK serotipova (npr. Massachusetts) prema lokalnom programu cijepljenja.
Pharmacotherapeutic group: Immunologicals for Aves, domestic fowl, live viral vaccine, avian infectious bronchitis virus.
Farmakoterapijska grupa: imunološki pripravci za ptice, domaću perad, živo virusno cjepivo, virus zaraznog bronhitisa ptica.
Read the package leaflet before use.
Pročitati uputu prije upotrebe.
The product should only be used after it has been established that IBV variant strain 4-91 is epidemiologically relevant in the area.
Proizvod treba primijeniti samo, nakon što je utvrđeno da je virus ZB, varijantni soj 4-91, epidemiološki relevantan u tom području.
Where the number of chickens is between the standard dosages, the next higher dosage should be used.
Ukoliko je broj pilića između standardnih broja doza, koristimo slijedeće pakiranje s većim brojem doza
Live IBV, 4-91
Živi virus ZB, 4-91
Ensure that all the vaccine suspension is consumed within 1-2 hours.
Treba osigurati da pilići popiju svu vodu s cjepivom u roku od 1-2 sata.
Since the stability of IBV in suspension may be low due to sensitivity to high temperatures and impurities, water used for dissolving the freeze-dried vaccine should be cool and of good quality.
Zbog slabije stabilnosti suspenzije virusa ZBK pri visokim temperaturama i u prisutnosti nečistoća, voda koju koristimo za otapanje liofiliziranog cjepiva treba biti hladna i dobre kvalitete.
a) the administration of the product to animals will interfere with the implementation of a national programme for the diagnosis, control or eradication of animal diseases, or will cause difficulties in certifying the absence of contamination in live animals or in foodstuffs or other products obtained from treated animals.
nadzor i iskorjenjivanje bolesti ili da bi prouzročila poteškoće u potvrđivanju odsutnosti zaraze u živih životinja ili prehrambenih i drugih proizvoda dobivenih od tretiranih životinja.
Vaccination with Nobilis IB 4-91 may very commonly induce mild respiratory signs of disease which may persist for a few days depending on the health and condition of the chickens.
Cjepljenje sa Nobilis IB 4-91 često može uzrokovati blage respiratorne simptome bolesti koje mogu trajati nekoliko dana ovisno o zdravlju i kondiciji pilića.
However, the chance of a hazard occurring has been estimated very low and is minimized by routinely vaccinating all chickens on the premise at the same time and cleaning and disinfection after each production round.
Ipak, šanse su vrlo male te su minimizirane rutinskim cijepljenjem svih pilića u prostoru, u isto vrijeme te čišćenjem i dezinficiranjem nakon svakog proizvodnog ciklusa.
Do not mix with any other veterinary medicinal product, except Nobilis IB Ma5 recommended for use with the veterinary medicinal product.
Ne miješati s bilo kojim veterinarsko medicinskim proizvodom, osim s preporučenim veterinarsko medicinskim proizvodom Nobilis IB Ma5.
Ocular/intranasal administration or coarse spray gives the best responses and these should be the methods of choice, especially when vaccinating young chickens.
Okularna/intranazalna primjena ili raspršivanje većih kapljica, daju najbolje imunosne odgovore i to bi trebala biti metoda izbora, pogotovo kod cijepljenja mladih pilića.
For the mixed products the onset of immunity is 3 weeks and the duration of immunity is 6 weeks for the claimed protection against the Massachusetts strains and the variant strain 4-91 of IBV.
Za kombiniranu primjenu početak imuniteta je 3 tjedna, a trajanje imuniteta je 6 tjedana, za utvrđenu zaštitu protiv sojeva Massachusetts i varijantu soja 4-91 ZBK-a.
The vaccine may be delivered as a freeze-dried cake in a glass vial or as freeze-dried spheres in cups.
Cjepivo može biti isporučeno kao liofilizirana peleta u staklenoj bočici ili kao liofilizirane kuglice u čašicama.
Special precautions to be taken by the person administering the veterinary medicinal product to animals In case of spray administration, personal protective equipment consisting of masks with eye protection should be worn when handling the veterinary medicinal product.
Kod primjene raspršivača, mora se pri rukovanju veterinarsko medicinskim proizvodom nositi oprema za osobnu zaštitu koja se sastoji od maske sa zaštitom za oči.
PARTICULARS TO APPEAR ON THE OUTER PACKAGE CARTON BOX with 1 vial, 10 vials or 10 cups of lyophilisate
PODACI NA VANJSKOM PAKOVANJU KARTONSKA KUTIJA sa 1 bočicom, 10 bočica ili 10 čašica liofilizata
Water withholding should be kept as short as possible with a minimum of half an hour.
Vrijeme trajanja uskraćivanja vode uvelike ovisi o klimatskim uvjetima i treba biti što je kraće moguće, a najmanje pola sata.
The vaccine should be given in the early morning as this is the main period of water intake or during the cool period on a hot day.
Cjepivo dajemo u ranim jutarnjim satima, jer životinje tada popiju najviše vode ili u svježijem dijelu dana tokom vrućina.
The vaccine suspension should be spread evenly over the correct number of chickens, at a distance of 30-40 cm using a coarse spray, preferably when the chickens are sitting together in dim light.
Suspenziju cjepiva treba pomoću raspršivača, s većim kapljicama, ravnomjerno raspršiti po točnom broju pilića, s udaljenosti od 30-40 cm, po mogućnosti, kada su pilići zajedno okupljeni pri prigušenom svjetlu.
1x 500 doses 1x 1,000 doses 1x 2,500 doses 1x 5,000 doses 1x 10,000 doses 10x 500 doses 10x 1,000 doses 10x 2,500 doses 10x 5,000 doses 10x 10,000 doses
1x 500 doza 1x 1000 doza 1x 2500 doza 1x 5000 doza 1x 10000 doza 10x 500 doza 10x 1000 doza 10x 2500 doza 10x 5000 doza 10x 10000 doza
1,000 doses (3-100 spheres) 2,500 doses (3-100 spheres) 5,000 doses (3-100 spheres) 10,000 doses (3-100 spheres)
1000 doza (3-100 kuglica) 2500 doza ( 3-100 kuglica) 5000 doza (3-100 kuglica) 10000 doza (3-100 kuglica)
Shelf life of the veterinary medicinal product in glass vials as packaged for sale: 9 months.
Rok valjanosti veterinarsko medicinskog proizvoda pakiranog za prodaju u staklenim bočicama: 9 mjeseci.
Sealed aluminium laminate cup with a polypropylene (cup) and polypropylene/polyethylene (lid) contact layer containing 1,000; 2,500; 5,000 or 10,000 doses.
Zapečaćena laminirana aluminijska čašica s kontaktnim slojem od polipropilena (čašica) i polipropilen/polietilena (poklopac) koja sadrži 1000, 2500, 5000 ili 10000 doza.
The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reaction(s)) - common (more than 1 but less than 10 animals in 100 animals treated) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - rare (more than 1 but less than 10 animals in 10,000 animals treated) - very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
Učestalost nuspojava je određena prema slijedećim pravilima: - vrlo česte (više od 1 u 10 životinja pokazuju nuspojave za vrijeme trajanja jednog tretmana) - česte (više od jedne ali manje od 10 životinja od 100 životinja) - manje česte (više od 1 ali manje od 10 životinja na 1000 životinja) - rijetke (više od 1 ali manje od 10 životinja na 10,000 životinja) - vrlo rijetke (manje od 1 životinje na 10,000 životinja, uključujući izolirane slučajeve).
By adding approximately 2 grams of skimmed milk powder or 20 ml of liquid skimmed milk per litre of water the virus retains its activity longer.
Dodavanje oko 2 grama obranog mlijeka u prahu ili 20 ml tekućeg obranog mlijeka po litri vode produžuje djelovanje aktivnosti virusnog cjepiva.
The spray apparatus should be free from sediments, corrosion and traces of disinfectants and ideally should be used for vaccination purposes only.
Uređaj za raspršivanje ne smije sadržavati sediment, koroziju i tragove dezinficijensa, najbolje da se koristi samo za cijepljenje.
In case of the latter presentation the cups may contain 3 up to 100 spheres depending on the required dosages and production yields.
Naredni dostupni oblici čašica mogu sadržavati od 3 do 100 kuglica ovisno o traženoj dozi i proizvodnim prinosa.
500 doses 1,000 doses 2,500 doses 5,000 doses 10,000 doses
500 doza 1000 doza 2500 doza 5000 doza 10000 doza
The same volumes as for the single product should be used.
Potrebno je upotrijebiti isti volumen kao kod davanja pojedinog cjepiva.
At least 3.6 log10 EID50 (1 dose) per animal by coarse spray, drinking water or intranasal/ocular administration.
Najmanje 3,6 log10 EID50 (1 doza) po životinji raspršivanjem, u vodi za piće ili intranazalno/okularno.
For administration of the vaccine, as a general rule, dissolve 1,000 doses in one litre per age in days up to a maximum volume of 20 litres per 1,000 doses.
Opće pravilo za cijepljenje je, otopiti 1000 doza u jednoj litri vode na starost pilića u danima, do maksimalne količine od 20 litara za 1000 doza.
The instructions on reconstitution of both lyophilisates and the subsequent application are to be followed as outlined above for spray and intranasal/ocular administration.
Treba slijediti upute za rekonstituciju oba liofilizata i naknadnu aplikaciju kako je prethodno navedeno, za sprej ili intranazalno/okularnu primjenu.
Dissolve the vaccine in physiological saline solution or sterile distilled water (usually 30 ml per 1,000 doses, 75 ml per 2,500 doses) and administer by means of a standardized dropper.
Cjepivo otopiti u fiziološkoj otopini ili sterilnoj destiliranoj vodi (obično 30 ml za 1000 doza, 75 ml za 2500 doza) i primijeniti pomoću standardne kapaljke.
One drop should be applied onto one nostril or one eye.
Dajemo po jednu kap u nosnicu ili oko.
Shelf life after reconstitution according to directions: 2 hours.
Rok valjanosti nakon rekonstituiranja prema uputama: 2 sata.
According to Article 71 of Directive 2001/82/EC of the European Parliament and of the Council as amended, a Member State may, in accordance with its national legislation, prohibit the manufacture, import, possession, sale, supply and/or use of immunological veterinary medicinal products on the whole or part of their territory if it is established that:
Prema članku 71. Direktive 2001/82/EZ, Europskog Parlamenta i Vijeća kako je izmijenjena, država članica može, sukladno nacionalnim odredbama zaštite zdravlja životinja, zabraniti proizvodnju,
Glass vial (type I hydrolytic glass) of 10 ml containing 500; 1,000; 2,500; 5,000 or 10,000 doses closed with a halogenobutyl rubber bung and sealed with a coded aluminium cap.
Staklena bočica (tip I hidrolitičko staklo) od 10 ml, koja sadrži 500, 1000, 2500, 5000 ili 10000 doza zatvorena s halogenbutil gumenim čepom i aluminijskom kapicom s oznakom.
Read the product information of Nobilis IB Ma5 before use.
Pročitati uputu za Nobilis IB Ma5 prije upotrebe.
6.6 Special precautions for the disposal of unused veterinary medicinal products or waste materials, derived from the use of such products
6.6 Posebne mjere opreza za odlaganje neupotrebljenog veterinarsko-medicinskog proizvoda ili otpadnih materijala dobivenih primjenom tih proizvoda
The vaccine should preferably be dissolved in distilled water or alternatively in cool, clean water.
Cjepivo je bolje otopiti u destiliranoj vodi ili u hladnoj, čistoj vodi.
The volume of water for reconstitution should be sufficient to ensure an even distribution when sprayed onto the chickens.
Količina vode za rekonstituciju cjepiva treba biti dovoljna da se pri raspršivanju osigura ravnomjerna raspodjela cjepiva.
Water should be withheld before vaccination to make the chickens thirsty.
Prije cijepljenja pilićima uskratimo vodu kako bi bili žedni.
Care should be taken to avoid spread of the vaccine virus from vaccinated chickens to pheasants.
Treba izbjeći širenje vakcinalnog virusa s pilića na fazane.